メニューにジャンプ コンテンツにジャンプ

トップページ > 当センターについて > 業績集 > ACC業績集 2007年

ACC業績集 2007年

英文

ACC Publications 2007

※PubMed等(外部サイト)にリンクします

  1. Bi X, Gatanaga H, Koike K, Kimura S, and Oka S. Reversal periods and patterns from drug resistant to wild type HIV-1 after cessation of anti-HIV therapy. AIDS Res Hum Retrovirus 23: 43-50, 2007.
  2. Yamanaka H, Gatanaga H, Kosalaraksa P, Matsuoka-Aizawa S, Kimura S, and Oka S. Novel mutation of human polymerase γ associated with mitochondrial toxicity induced by anti-human immunodeficiency virus treatment. J Infect Dis 195: 1419-1425, 2007.
  3. Gatanaga H, Yazaki H, Tanuma J, Honda M, Genka I, Teruya K, Tachikawa N, Kikuchi Y, and Oka S. HLA-Cw8 primarily associated with hypersensitivity to nevirapine. AIDS (correspondence) 21: 264-265, 2007.
  4. Honda M, Yogi A, Ishizuka N, Genka I, Gatanaga H, Teruya K, Tachikawa N, Kikuchi Y, and Oka S. Effectiveness of subcutaneous growth hormone in HIV-1 patients with moderate to severe facial lipoatrophy. Intern Med 46: 359-362, 2007.
  5. Gatanaga H, Ibe S, Matsuda M, Yoshida S, Asagi T, Kondo M, Sagamatsu K, Tsukada H, Masakane A, Mori H, Takata N, Minami R, Tateyama M, Koike T, Itoh T, Imai M, Nagashima M, Gejyo F, Ueda M, Hamaguchi M, Kojima Y, Shirasaka T, Kimura A, Yamamoto M, Fujita J, Oka S, and Sugiura W. Drug-Resistant HIV-1 Prevalence in Patients Newly Diagnosed with HIV/AIDS in Japan. Antiviral Res 75: 75-82, 2007.
  6. Vasilescu A, Terashima Y, Enomoto M, Heath S, Poonpiriya V, Gatanaga H, Do H, Diop G, Hirtzig T, Charneau P, Marullo S, Oka S, Kanegasaki M, Lathrop M, Matsushima K, Zagury JF, and Matsuda F. A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1 patients. PNAS 104: 3354-3359, 2007
  7. Ueno T, Idegami Y, Motozono C, Oka S, and Takiguchi M. Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs. J Immunol 178: 5513-5523, 2007.
  8. Koike K, Tsukada K, Yotsuyanagi H, Moriya K, Kikuchi Y, Oka S, and Kimura S. Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan. Hepatol Res 37: 2-5, 2007.
  9. The ESPRIT Research Group (Kikuchi Y, Takano M, Oka S as members of Japan National Trial Coordinating Center). Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>300 cells/μl who were assigned to 7.5 MIU interleukin-2. HIV Med 8: 112-123, 2007.
  10. Gatanaga H, Hayashida T, Tsuchiya K, Yoshino M, Kuwahara T, Tsukada H, Fujimoto M, Sato I, Ueda M, Horiba M, Hamaguchi M, Yamamoto M, Takata N, Kimura A, Koike T, Gejyo F, Mastushita S, Shirasaka T, Kimura S, and Oka S. Successful dose reduction of efavirenz in HIV-1-infected cytochrome P450 2B6 *6 and *26 holders. Clin Infect Dis 45: 1230-1237, 2007.
  11. Katano H, Sato Y, Hoshino S, Tachikawa N, Oka S, Morishita Y, Ishida T, Watanabe T, Rom WN, Mori S, Sata T, Weiden MD, and Hoshino Y. Integration of HIV-1 caused STAT3-associated B cell lymphoma in an AIDS patient Microbes Infect 9: 1581-1589, 2007.
  12. Fujiwara M, Tanuma J, Koizumi H, Kawashima Y, Honda K, Matsuoka AS, Dohki S, Oka S, and Takiguchi M. Accumulation of HIV-1 escape mutant by different responses of escape mutant-specific cytotoxic T cells to escape mutant and wild-type HIV-1 in new hosts. J Virol 82: 138-147, 2008, Epub 2007 Oct 24.

和文

準備中

国際学会

準備中

国内学会

準備中